This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

Close Message
NextPharmaJob.com for pharmaceutical industry jobs
Lucid centre of excellence
NextPharmaJob.com is dedicated to putting job seekers looking for pharmaceutical industry jobs in touch with recruiters and employers.
Browse Jobs Search Jobs

To receive a FREE weekly email alert of all the latest pharmaceutical industry jobs added to our database enter your email address below.

Submit | Tell me more...

Sister sites:
Our sister site Our sister site
Partner sites:

At Burntsky Limited we work with a number of third parties in order to maximise the reach of the jobs posted with us including but not limited to:

JooblePartner Jooble
UK Jobs
Science Jobs

Industry News
01 April 2020 14:30For IBS Awareness Month, a free trial offer to help improve IBS symptoms
CHICAGO, April 1, 2020 /PRNewswire/ -- During April, IBS Awareness Month, biotech company Glycom is offering a free trial offer of Holigos® IBS Restore for people suffering from abdominal pain, bloating, constipation or diarrhea caused by irritable

01 April 2020 14:29Therapix Biosciences Announces Pricing of $1.25 Million Public Offering
TEL AVIV, Israel, April 1, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced

01 April 2020 14:26Karo Pharma Publishes the 2019 Annual Report
HUDDINGE, Sweden, April 1, 2020 /PRNewswire/ -- Today, on 1 April 2020, Karo Pharma is publishing its annual report for 2019 on the company's website, www.karopharma.com. ABOUT KARO PHARMA Karo Pharma specialises in the sales and marketing of presc

01 April 2020 14:13FibroGenesis ha expandido el alcance de su patente
FibroGenesis ha expandido el alcance de la patente de su tratamiento de fibroblastos para tratar SDRA por coronavirus (COVID/19) La compañía informa de una excelente sinergia entre el tratamiento de fibroblastos e hidroxicloroquina  HOUSTON, 1 d

01 April 2020 14:13FibroGenesis dépose une couverture de brevet élargie pour sa thérapie cellulaire par fibroblastes dans le traitement du syndrome de détresse respiratoire aiguë du coronavirus (COVID-19)
La société annonce une synergie puissante entre sa thérapie cellulaire par fibroblastes et l'hydroxychloroquine HOUSTON, 1er avril 2020 /PRNewswire/ -- FibroGenesis, une société de médecine régénérative basée au Texas, axée sur la régénération ti

01 April 2020 14:13FibroGenesis Files Expanded Patent Coverage for its Fibroblast Cell Therapy to treat Coronavirus (COVID-19) ARDS
HOUSTON, April 1, 2020 /PRNewswire/ -- FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibroblasts (HDFs), today announced the filing of United States Provisio

01 April 2020 14:13FibroGenesis vraagt uitgebreide octrooidekking aan voor zijn Fibroblast-celtherapie voor de behandeling van Coronavirus (COVID-19) ARDS
Het bedrijf meldt een krachtige synergie tussen zijn Fibroblast-gebaseerde celtherapie en hydroxychloroquine   HOUSTON, 1 April 2020 /PRNewswire/ -- FibroGenesis is een in Texas gevestigd bedrijf voor regeneratieve geneeskunde, dat zich richt op

01 April 2020 14:13FibroGenesis meldet erweiterten Patentschutz für seine Fibroblasten-Zelltherapie zur Behandlung von Coronavirus (COVID-19) ARDS an
Das Unternehmen hat potente Synergie zwischen fibroblastbasierter Zelltherapie und Hydroxychloroquin festgestellt  HOUSTON, 1. April 2020 /PRNewswire/ -- FibroGenesis, ein Unternehmen für regenerative Medizin mit Sitz in Texas, das sich auf die G

01 April 2020 14:02Macromoltek Announces Computational De Novo Antibody Design Offering, Targeting COVID-19
AUSTIN, Texas, April 1, 2020 /PRNewswire/ -- Macromoltek, Inc. today announced computational de novo design capability to speed up the development of human monoclonal antibodies for the potential treatment of COVID-19. Traditional drug discovery is

01 April 2020 13:40Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19
NEW YORK, April 1, 2020 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, is pleased to provide the following

01 April 2020 13:15Trovagene Announces Acceptance of Phase 1b/2 KRAS-Mutated Metastatic Colorectal Cancer (mCRC) Trial Abstract for Presentation at the 2020 ASCO Annual Meeting
SAN DIEGO, April 1, 2020 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, oncology therapeutics company developing onvansertib for the treatment of various cancers including colorectal, prostate and leukemia, announced today that i

01 April 2020 13:07Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
CRANFORD, N.J., April 1, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today signed an exclusi

01 April 2020 13:00Santen Inc. Announces Appointment of Tatsuya Kaihara as Corporate Officer and Head of North America Business of Santen Pharmaceutical
EMERYVILLE, Calif., April 1, 2020 /PRNewswire/ -- Santen Inc., a U.S. subsidiary of Santen Pharmaceutical Co., Ltd., a global company focused exclusively on ophthalmology, today announced the appointment of Tatsuya Kaihara as Corporate Officer and

01 April 2020 13:00Seneca Biopharma Announces Executive Appointments and Key Promotion
GERMANTOWN, Md., April 1, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a clinical-stage biopharmaceutical company developing novel treatments for diseases of high unmet medical need, announced today the appointment of Matthew W. Kaln

01 April 2020 12:30Stealth BioTherapeutics Reports Fiscal Year 2019 Financial Results And Recent Business Highlights
BOSTON, April 1, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dys

01 April 2020 12:30InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
VANCOUVER, April 1, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way

01 April 2020 12:00CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2019
REHOVOT, Israel, April 1, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced financial results for the full year ended December 31, 2019 and provided an update on the Company's business de

01 April 2020 12:00MindMed Acquires Exclusive License to Eight Clinical Trials of LSD, Partners with World-Leading Psychedelic Research Laboratory at University Hospital Basel
BASEL, Switzerland, April 1, 2020 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NEO: MMED OTC: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines, today announced the signing of a multi-year, branch exclusive collab

01 April 2020 11:20Akorn Provides Update on Sale Process
LAKE FOREST, Ill., April 1, 2020 /PRNewswire/ -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it no longer has any bids in the Sale Process that are sufficient to pay all obligations under its term lo

01 April 2020 11:12Clarity nombra al Dr. Gillies O'Bryan-Tear presidente del recientemente formado grupo de Desarrollo Clínico Global
SÍDNEY, martes, 1 de abril de 2020  /PRNewswire/ -- Clarity Pharmaceuticals, una empresa de radiofarmacia centrada en el tratamiento de enfermedades graves, se complace en anunciar que el Dr. Gillies O'Bryan-Tear presidirá el nuevo grupo de Desarro
News last updated 01/04/2020 14:35:13
line graphic

Compatible with:

JobMate   Broadbean   Idibu

Site optimised for Internet Explorer 8+ / Firefox 3+
View a complete Jobs Listing




Credit cards image